Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PI3K/AKT/mTOR signalling pathway involvement in renal cell carcinoma pathogenesis (Review)
Daniela Miricescu, Daniela Bălan, Adrian Tulin, et al.
Experimental and Therapeutic Medicine (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 78

Showing 26-50 of 78 citing articles:

A precision medicine approach to metabolic therapy for breast cancer in mice
Ngozi D. Akingbesote, Aaron D. Norman, Wanling Zhu, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 13
Polygenic risk score model for renal cell carcinoma in the Korean population and relationship with lifestyle-associated factors
Joo Young Hong, Jang Hee Han, Seung Hwan Jeong, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Same Organ, Two Cancers: Complete Analysis of Renal Cell Carcinomas and Upper Tract Urothelial Carcinomas
Sorin Vameşu, Oana Andreea Ursica, S Milea, et al.
(2024)
Open Access | Times Cited: 2
Collagen Type V Alpha 2 Promotes the Development of Gastric Cancer via M2 Macrophage Polarization
Xin Guo, Xiaoqian Bu, Li Yuan, et al.
The Chinese Journal of Physiology (2023) Vol. 66, Iss. 2, pp. 93-102
Closed Access | Times Cited: 6
Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery
Jennifer Ma, Luke del Balzo, Henry Walch, et al.
European Urology Oncology (2024)
Closed Access | Times Cited: 2
Resveratrol liposomes reverse sorafenib resistance in renal cell carcinoma models by modulating PI3K-AKT-mTOR and VHL-HIF signaling pathways
Ligang Wang, Ying Wang, Qiqi Xie, et al.
International Journal of Pharmaceutics X (2024) Vol. 8, pp. 100280-100280
Open Access | Times Cited: 2
Overexpression of cytoplasmic dynamin 2 is associated with worse outcomes in patients with clear cell renal cell carcinoma
Sadegh Safaei, Roya Sajed, Leili Saeednejad Zanjani, et al.
Cancer Biomarkers (2022) Vol. 35, Iss. 1, pp. 27-45
Closed Access | Times Cited: 10
CircRNF220 plays a pathogenic role to facilitate cell progression of AML in vitro via sponging miR-330-5p to induce upregulation of SOX4.
Zewen Zhang, Shujun Lin, Jun Yin, et al.
PubMed (2022) Vol. 37, Iss. 10, pp. 1019-1030
Closed Access | Times Cited: 8
Methylglyoxal-Derived Advanced Glycation End Products (AGE4) Promote Cell Proliferation and Survival in Renal Cell Carcinoma Cells through the RAGE/Akt/ERK Signaling Pathways
Han-Kyul Nam, S.Y. Jeong, Min Cheol Pyo, et al.
Biological and Pharmaceutical Bulletin (2021) Vol. 44, Iss. 11, pp. 1697-1706
Open Access | Times Cited: 10
TMAO Suppresses Megalin Expression and Albumin Uptake in Human Proximal Tubular Cells Via PI3K and ERK Signaling
Stefania Kapetanaki, Ashok Kumar Kumawat, Katarina Persson, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8856-8856
Open Access | Times Cited: 7
Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker–driven learning framework
Sabrina H. Rossi, Izzy Newsham, Sara Pita, et al.
Science Advances (2022) Vol. 8, Iss. 39
Open Access | Times Cited: 7
The role of natural products versus miRNA in renal cell carcinoma: implications for disease mechanisms and diagnostic markers
A. Ayed
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 9, pp. 6417-6437
Closed Access | Times Cited: 1
Case report: Uncommon gastric metastasis as a presentation of recurrent clear cell renal cell carcinoma
Josep Sabaté-Ortega, Marc Albert-Carrasco, Carmen Escribano-Ferrer, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Research progress on Alpinia oxyphylla in the treatment of diabetic nephropathy
Jing Wang, Xiaomin Wang, Tianpeng Ma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
The JAK-STAT signaling-related signature serves as a prognostic and predictive biomarker for renal cell carcinoma immunotherapy
Szehoi Chan, Zixuan Liu, Yingying Chen, et al.
Gene (2024) Vol. 927, pp. 148719-148719
Closed Access | Times Cited: 1
ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma Cell Proliferation and Suppresses Angiogenesis by Attenuating PI3K/AKT/mTOR Pathway
Xiaochun Qin, Mingyue Liu, Chang Xu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Molecular mechanisms and physiological functions of autophagy in kidney diseases
Jingchao Yang, Longhui Yuan, Fei Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Pneumocystis jirovecii diagnosed by next-generation sequencing of bronchoscopic alveolar lavage fluid: A case report and review of literature
Qing-Wei Cheng, Hongli Shen, Zhihui Dong, et al.
World Journal of Clinical Cases (2023) Vol. 11, Iss. 4, pp. 866-873
Open Access | Times Cited: 3
Terrestrial Compound Protein Replacing Dietary Fishmeal Improved Digestive Enzyme Activity, Immune Response, Intestinal Microflora Composition, and Protein Metabolism of Golden Pompano (Trachinotus ovatus)
Yongcai Ma, Z.W. Su, Fang Chen, et al.
Aquaculture Nutrition (2023) Vol. 2023, pp. 1-18
Open Access | Times Cited: 3
Molecular insight into renal cancer and latest therapeutic approaches to tackle it: an updated review
Reshma Murali, Abilash Valsala Gopalakrishnan
Medical Oncology (2023) Vol. 40, Iss. 12
Closed Access | Times Cited: 3
CD44 Receptor-Targeted and Reactive Oxygen Species-Responsive H2S Donor Micelles Based on Hyaluronic Acid for the Therapy of Renal Ischemia/Reperfusion Injury
Xiudi Zhou, Qiang Chen, Chunjing Guo, et al.
ACS Omega (2022) Vol. 7, Iss. 46, pp. 42339-42346
Open Access | Times Cited: 5
Preclinical evaluation of the dual mTORC1/2 inhibitor sapanisertib in combination with cisplatin in nasopharyngeal carcinoma
Jian-Bin Zhang, Yan Jiang, Ye Yu, et al.
European Journal of Pharmacology (2021) Vol. 915, pp. 174688-174688
Closed Access | Times Cited: 7
Non-Clear Cell Renal Cell Carcinoma: Molecular Pathogenesis, Innovative Modeling, and Targeted Therapeutic Approaches
Niloofar Khoshdel Rad, Maryam Vahidyeganeh, Mahsa Mohammadi, et al.
International Journal of Translational Medicine (2022) Vol. 2, Iss. 4, pp. 555-573
Open Access | Times Cited: 5
Tumor suppressor LHX6 upregulation contributes to the inhibitory effect of miR‐346 knockdown on colorectal cancer cell growth
Xianzhe Li, Yeqi Zhou, Penghao Wen, et al.
Environmental Toxicology (2021) Vol. 37, Iss. 3, pp. 435-445
Closed Access | Times Cited: 6
Impact of COVID-19 Infection on Liver Transplant Recipients: Does It Make Any Difference?
Daniela Punga, Sebastian Isac, Cristian Paraipan, et al.
Cureus (2022)
Open Access | Times Cited: 4

Scroll to top